Price Move History
- Daily moves over 5%
- 11 60 sessions, September 25, 2025 to October 6, 2026
- Largest daily move
- +400% close of March 16, 2026
- 1-year change
- +0% closing prices, September 25, 2025 to October 6, 2026
- 1-month change
- +0% closing prices, September 4, 2026 to October 6, 2026
Company Description
NEMAURA MEDICAL (OTC: NMRD) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $4.0K.
NMRD has gained 0.0% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for NMRD, including price data, latest news, and short interest trends.
Stock Performance
NEMAURA MEDICAL (NMRD) closed at $0.0001 on October 6, 2026. Over the past 12 months, the price has gained 0.0%.
NMRD Metrics & Rankings
Price returns through October 6, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NEMAURA MEDICAL has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, management, AI, conferences. View all NMRD news →
SEC Filings
Short Interest History
Short interest in NEMAURA MEDICAL (NMRD) currently stands at 365 shares, representing 0.0% of the float.
Days to Cover History
Days to cover for NEMAURA MEDICAL (NMRD) currently stands at 1.1 days, up 14% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
NMRD Company Profile & Sector Positioning
NEMAURA MEDICAL (NMRD) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing NMRD often look at related companies in the same sector, including PRESSURE BIOSCIENCES (PBIO), THERMOGENESIS HLDGS INC (THMO), OPGEN INC (OPGN), MANHATTAN SCIENTIFICS INC (MHTX), and ALR TECHNOLOGIES SG LTD (ALRTF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NMRD's relative position within its industry.